Prognostic significance of double product and inadequate double product response to maximal symptom-limited exercise stress testing after myocardial infarction in 6,296 patients treated with thrombolytic agents

MLA

Villella, Massimo, et al. “Prognostic Significance of Double Product and Inadequate Double Product Response to Maximal Symptom-Limited Exercise Stress Testing after Myocardial Infarction in 6,296 Patients Treated with Thrombolytic Agents.” American Heart Journal, vol. 137, no. 3, Mar. 1999, p. 443. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.54145435&authtype=sso&custid=ns315887.

APA

Villella, M., Villella, A., Barlera, S., Franzosi, M. G., & Maggioni, A. P. (1999). Prognostic significance of double product and inadequate double product response to maximal symptom-limited exercise stress testing after myocardial infarction in 6,296 patients treated with thrombolytic agents. American Heart Journal, 137(3), 443.

Chicago

Villella, Massimo, Alessandro Villella, Simona Barlera, Maria Grazia Franzosi, and Aldo P. Maggioni. 1999. “Prognostic Significance of Double Product and Inadequate Double Product Response to Maximal Symptom-Limited Exercise Stress Testing after Myocardial Infarction in 6,296 Patients Treated with Thrombolytic Agents.” American Heart Journal 137 (3): 443. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.54145435&authtype=sso&custid=ns315887.